Impact of Symptomatic COVID-19 on the Oral Health of Pediatric Patients in Tbilisi City.

Publication date: May 31, 2025

Coronavirus disease 2019 (COVID-19) has become the cause of a global health crisis during the pandemic. This research aimed to study the impact of symptomatic COVID-19 on children’s oral health indices and salivary microbiome composition during the post-COVID-19 period. An observational, cross-sectional study was conducted in Tbilisi (Georgia) among children aged 7-12 years. A total of 421 children included in the study had a history of laboratory-confirmed COVID-19 within one year of exposure. No participants met the criteria for comorbid conditions or for PCC. A stratified simple random selection of schools and among selected clusters was used. The selected children were divided into two groups: the exposed group, who were patients with a history of symptomatic COVID-19, and the control group, who were patients with a history of asymptomatic COVID-19. The data were collected from August 2022 to December 2023. Oral screening, microbiological examination of saliva, and administration of questionnaires were also performed. Logistic regression was used to calculate ORs with 95% confidence intervals. The statistical processing of the data was performed with SPSS 23. 0. This study was approved by the Biomedical Research Ethical Council of the University of Georgia (UGREC-04-22/9 March 2022). Statistically significant differences in the means of the oral health indicators between the studied groups were detected (exposed: DMFT + deft = 5. 9; MGI = 0. 92; S-OHI = 1. 9; control: DMFT + deft = 3. 8; MGI = 0. 56; S-OHI = 1. 4). According to the logistic regression, symptomatic COVID-19 had a significant effect on the following oral health indicators: DMFT + deft (OR = 1. 26; 95% CI = 1. 14-1. 39), MGI (OR = 2. 31; 95% CI = 1. 50-3. 55), and S-OHI (OR = 3. 43; 95% CI = 2. 03-5. 76). The effect of symptomatic COVID-19 on the frequency of eradication of the studied microbiome was also significant (OR = 2. 12; 95% CI = 1. 23-3. 63). A close association was established between symptomatic COVID-19 and microbiome changes in the oral saliva of children, as well as between oral health indicators and symptomatic COVID-19. Considering the research results, it is assumed that a symptomatic course of COVID-19 may be an additional risk factor associated with poor oral health in the pediatric population in the post-COVID-19 period.

Open Access PDF

Concepts Keywords
Coronavirus COVID-19
December oral health indicators
Georgia oral microbiome
Microbiological population-based research

Semantics

Type Source Name
disease MESH COVID-19
disease MESH Oral Health
disease IDO history
drug DRUGBANK Methionine
drug DRUGBANK Factor IX Complex (Human)
disease MESH Mania
disease IDO country
disease MESH sore throat
disease MESH smell disorders
disease MESH oral candidiasis
disease MESH gingivitis
disease MESH Cheilitis
disease MESH inflammation
disease IDO symptom
drug DRUGBANK Angiotensin II
drug DRUGBANK Serine
disease MESH sialadenitis
disease MESH xerostomia
disease MESH altered taste
drug DRUGBANK L-Glutamine
disease MESH infection
disease MESH facial asymmetry
disease MESH bleeding
disease MESH ulcer
disease MESH hypersalivation
drug DRUGBANK Gold
disease IDO process
disease MESH taste disorders
disease MESH taste Loss
disease MESH periodontal diseases
drug DRUGBANK Isoxaflutole
pathway REACTOME Immune System
disease MESH carious lesions
disease MESH chronic diseases
drug DRUGBANK Coenzyme M
pathway KEGG Coronavirus disease
disease IDO cell
drug DRUGBANK Efavirenz
disease MESH Ectasia
disease MESH complications
disease MESH Morbidity
disease MESH Allergy
disease IDO susceptibility
disease MESH tic
drug DRUGBANK Guanosine
disease MESH dysbiosis
disease MESH Cystic Fibrosis
drug DRUGBANK Bismuth subgallate
disease MESH asymptomatic infections

Original Article

(Visited 1 times, 1 visits today)